What’s Happening in Cardiology That Not Everyone Is Talking About ❤️🔥 As we look ahead to 2025, the pace of innovation in cardiology is undeniable—but some of the most transformative trends are flying under the radar. Here are five developments worth paying attention to: 1️⃣ Prevention, Personalized. Finally. “Statins for everyone” is giving way to something smarter. AI-powered risk tools 🤖 and precision lipid management 🧬 are ushering in an era of highly individualized prevention. Think tailored solutions that meet patients exactly where they are—not just where the guidelines tell us they should be. 2️⃣ Cardio-Oncology Comes of Age. Cancer and cardiology have more in common than we used to think. As more patients survive cancer (a win, no question!), cardio-oncology is stepping up to address the long-term heart risks that come with it. Managing chemo cardiomyopathy and radiation coronary disease isn’t a side gig anymore—it’s core to modern care. 3️⃣ Hybrid Care Hits Its Stride. The pendulum swung hard to virtual care over the past few years, but 2025 is about finding balance. Hybrid models—seamlessly combining in-person precision with digital convenience 🏥📱—are delivering more thoughtful, patient-centered care. 4️⃣ Continuous Care, Quietly Revolutionized. Remote monitoring is evolving fast. It’s not just wearables anymore—it’s implantables, biosensors, and even passive smartphone data 📲. These tools are taking us from episodic check-ins to continuous, real-time connections with patients. 5️⃣ The GLP-1 Revolution. GLP-1 receptor agonists are proving they’re much more than diabetes drugs 💊. From weight loss to heart failure outcomes, these therapies are fundamentally changing how we think about metabolic health—and their ripple effects in cardiology are just beginning. 2025 isn’t shaping up to be just another year in cardiology—it’s poised to be a turning point. These trends might not grab headlines, but they’re driving the kind of progress that changes lives (and saves them). What under-the-radar innovations are you keeping an eye on? #Cardiology #HeartHealth #Innovation #2025Trends
“These trends might not grab headlines, but they’re driving the kind of progress that changes lives (and saves them).” - Well said 👏
+1 on continuous and hybrid care. And we'll see more of the Attia/Med 3.0 effect on the preventive side: ApoB > standard lipids, Lp(a) once, more CAC use and coverage, and hopefully more use of the PREVENT 30 year risk calculator.
Thank you for the Cardio-Oncology shout out! We are consistently tailoring precision management as it relates to the cancer population and finding new ways to improve cancer survivorship. If you like merging discovery with clinical care, this is the field for you.
Jeffrey Wessler , any thoughts or comments on the shift of interventions from inpatient to outpatient (ASC)? Or, does SOS shift not fall into the the bucket of “not being talked about” subjects?
Lots of reasons to be optimistic about the next 5-10 years!
Love it. Was “pace” of innovation intentional? 😃
Healthtech Exec Committed to Patient-First Innovation | Ro Employee #3 | Startup Leader | Strategic Advisor | Builder of High-Performing Teams
1dGuidelines can both overestimate and underestimate risk, but they are also written for the relative short term (10 year risk). In addition, they completely ignore several studies looking at more nuanced lipid treatment, like low dose statin + ezetimibe being better options than high dose statins in terms of decreased side effects, better treatment retention, and similar protection. However, guidelines are not useless. They are just guidelines. They shouldn't be used as plug and play manuals.